Safety Centre
The boring part that actually matters
General educational context only — no personalised risk assessments, no protocols. If something feels wrong in your body, that is a conversation for a clinician, not a forum.
Three very different categories
These labels describe the legal and testing position of a compound — not how safe or effective it is.
Regulatory status is jurisdiction-, product-, formulation- and indication-specific. An approval in one country does not imply approval elsewhere or for every use. Regulatory status is separate from efficacy evidence, safety and recommendations.
Approved medicines
A regulator has judged the evidence good enough for named conditions. Approved means vetted, not safe for everyone or for every use.
- A regulator has reviewed manufacturing, trial data, risks and benefits for a specific licensed use (the 'indication').
- Side effects are collected systematically after launch, so the risk picture keeps improving over time.
- Approval is use-specific. A medicine approved for one condition is not automatically validated — or safe — for another.
Investigational compounds (in clinical trials)
Still being tested in formal human trials. Being in trials is not the same as nearly approved, and it is not proof the compound works.
- In formal clinical trials with ethics oversight, defined protocols and monitored participants.
- Early results can look genuinely strong while long-term safety remains unknown — both are true at once, and many trial compounds never get approved.
- Anything sold to the public under an investigational drug's name sits outside that oversight entirely.
Experimental / research compounds
Nobody has vetted these for human use. That means unknown, not proven dangerous — but unknown is a reason for caution, not reassurance.
- No approval, usually no human safety dataset, and frequently no data at all on what the body does with the compound.
- 'Research use only' is a legal disclaimer, not a quality standard or a safety assurance.
- Real-world use typically involves self-injection without monitoring, which adds risks separate from the molecule itself.
Common versus serious — in general terms
Commonly reported effects
Across the incretin class, gastrointestinal effects dominate: nausea, vomiting, constipation, diarrhoea, reduced appetite. They are usually dose-related and often ease with time. Across injected peptides generally, injection-site reactions, headache and fluid retention are frequently described.
Serious but less common concerns
Depending on the compound and class, these can include pancreatitis, gallbladder problems, severe dehydration from persistent vomiting, significant hormonal or metabolic disturbance, allergic reactions and infection from non-sterile injection practice. Specific risks differ by compound and by person.
Product and manufacturing quality
- Unapproved supply chains have documented problems: incorrect content, wrong quantity, impurities, degradation and non-sterile preparation.
- A certificate of analysis provided by the seller is not independent verification — the incentive problem is obvious.
- Reconstitution, storage and sterile technique introduce risks that have nothing to do with the molecule's pharmacology.
- This site does not review, rank or link to suppliers, and never will. That is not the job.
Why 'nobody reported harm' proves nothing
- There is no systematic adverse-event reporting system for compounds sold outside medical supply.
- People who stop using something because it felt wrong rarely post an update; survivorship bias runs strong in enthusiast communities.
- Delayed, rare or non-obvious harms — the ones that matter most — are exactly what anecdote cannot detect.
- Absence of evidence of harm is not evidence of absence of harm. It is just absence.
Cancer risk: how to think about it honestly
Mechanistic concern is not demonstrated human risk
When urgent medical care is appropriate
In general educational terms, symptoms that warrant urgent assessment include severe or persistent abdominal pain, persistent vomiting or inability to keep fluids down, signs of an allergic reaction such as facial swelling or breathing difficulty, chest pain, fainting, spreading redness, swelling or fever after an injection, or any sudden severe symptom you can’t explain.
This is generic educational information, not triage. If you are worried about symptoms right now, contact your local emergency or urgent care service — and tell them everything you have taken. They need the full picture, not an edited one.